Speeding therapies to market requires more than faster development; it demands a smarter regulatory strategy. This eBook explores how life sciences organizations are leveraging expedited regulatory pathways, reliance procedures and global regulatory collaborations to accelerate approvals while maintaining regulatory rigor. Learn how FDA, EMA and PMDA accelerated pathways are being used in practice, how reliance models and consortia initiatives can support global submissions, and why regulatory intelligence is critical for navigating evolving requirements and bringing innovative therapies to patients faster.